In our 200th Episode, IDx Founder Shares Wisdom from Recent Success with the FDA, Venture Investors

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 200″]

First, thanks to everyone who has helped make the OIS Podcast such a success. We at Healthegy – the producer of the OIS Podcast and events – are grateful for your support. In this week’s episode, we’re visited again by Michael Abramoff, MD, founder and CEO of IDx, the first company to obtain FDA approval for an AI diagnostic tool. In this interview, Dr. Abramoff explains how IDx-DR, an autonomous AI diagnostic for diabetic retinopathy, worked its way through the FDA. He also shares the process he used to raise $33 million from a syndicate of high-powered investors including 8VC, Optum Ventures, Alpha Edison, and Heritage Provider Network. What’s the next step for IDx? Is it an IPO?